Life sciences and healthcare
Federal Council of Medicine (CFM) regulates the relationship between doctors and industry. New resolution comes into force in March 2025.
Federal Pharmacy Council regulates pharmaceutical practice in digital health and AI. New regulation allows the prescription of digital therapies.
Anvisa publishes notice for collecting contributions on the regulatory sandbox proposal. Public call of subsidies runs from August 12 to October 11.
Ebook: New rules for public private partnership under the Brazilian Health Industrial Complex (CEIS)
Our updated ebook New Rules for Private Partnerships under the Brazilian Health Industrial Complex (CEIS) details recent public policies issued by the Brazilian Ministry of Health for strengthening the Unified Health System (SUS) industry and...
New regulation from the National Health Surveillance Agency (Anvisa) establishes a pilot project for the gradual implementation of digital drug leaflets.
Anvisa approves the National Prescription Control System to improve, to streamline the numbering and control of prescriptions for controlled-use medications.
MS publishes new rules for the Partnerships for Productive Development (PDP) program and the Local Innovation Development Program (PDIL).
Bill 6.007/23, which addresses the requirements for carrying out research with human beings in Brazil, is heading for presidential sanction.
Anvisa establishes an optimized procedure for the analysis of medical device Marketing Authorizations recognized by an equivalent foreign regulatory authority.
Ministry of Health discloses actions to comply with TCU determinations on Partnerships for Productive Development, which had been suspended.
The Brazilian healthcare system has been undergoing an intense process of digital transformation, through the application of technological tools such as AI, blockchain, IoT, and others in management processes, research & development...
Bill of Law No. 7.082/17 approved by the Brazilian House of Representatives addresses requirements for conducting research with human beings in Brazil.
